406 related articles for article (PubMed ID: 11395480)
1. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway.
Haÿ E; Lemonnier J; Fromigué O; Marie PJ
J Biol Chem; 2001 Aug; 276(31):29028-36. PubMed ID: 11395480
[TBL] [Abstract][Full Text] [Related]
2. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts.
Nöth U; Tuli R; Seghatoleslami R; Howard M; Shah A; Hall DJ; Hickok NJ; Tuan RS
Exp Cell Res; 2003 Nov; 291(1):201-11. PubMed ID: 14597420
[TBL] [Abstract][Full Text] [Related]
3. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation.
Suzawa M; Tamura Y; Fukumoto S; Miyazono K; Fujita T; Kato S; Takeuchi Y
J Bone Miner Res; 2002 Feb; 17(2):240-8. PubMed ID: 11811554
[TBL] [Abstract][Full Text] [Related]
5. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription.
Ghosh-Choudhury N; Abboud SL; Nishimura R; Celeste A; Mahimainathan L; Choudhury GG
J Biol Chem; 2002 Sep; 277(36):33361-8. PubMed ID: 12084724
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2.
Viñals F; López-Rovira T; Rosa JL; Ventura F
FEBS Lett; 2002 Jan; 510(1-2):99-104. PubMed ID: 11755539
[TBL] [Abstract][Full Text] [Related]
7. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
Lee KS; Hong SH; Bae SC
Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
[TBL] [Abstract][Full Text] [Related]
8. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation.
Spinella-Jaegle S; Roman-Roman S; Faucheu C; Dunn FW; Kawai S; Galléa S; Stiot V; Blanchet AM; Courtois B; Baron R; Rawadi G
Bone; 2001 Oct; 29(4):323-30. PubMed ID: 11595614
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway.
Izumi M; Fujio Y; Kunisada K; Negoro S; Tone E; Funamoto M; Osugi T; Oshima Y; Nakaoka Y; Kishimoto T; Yamauchi-Takihara K; Hirota H
J Biol Chem; 2001 Aug; 276(33):31133-41. PubMed ID: 11408477
[TBL] [Abstract][Full Text] [Related]
10. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells.
Gallea S; Lallemand F; Atfi A; Rawadi G; Ramez V; Spinella-Jaegle S; Kawai S; Faucheu C; Huet L; Baron R; Roman-Roman S
Bone; 2001 May; 28(5):491-8. PubMed ID: 11344048
[TBL] [Abstract][Full Text] [Related]
11. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.
Lee KS; Kim HJ; Li QL; Chi XZ; Ueta C; Komori T; Wozney JM; Kim EG; Choi JY; Ryoo HM; Bae SC
Mol Cell Biol; 2000 Dec; 20(23):8783-92. PubMed ID: 11073979
[TBL] [Abstract][Full Text] [Related]
12. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
13. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.
Guicheux J; Lemonnier J; Ghayor C; Suzuki A; Palmer G; Caverzasio J
J Bone Miner Res; 2003 Nov; 18(11):2060-8. PubMed ID: 14606520
[TBL] [Abstract][Full Text] [Related]
14. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways.
Celil AB; Campbell PG
J Biol Chem; 2005 Sep; 280(36):31353-9. PubMed ID: 16000303
[TBL] [Abstract][Full Text] [Related]
15. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.
Nishimura R; Hata K; Harris SE; Ikeda F; Yoneda T
Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083
[TBL] [Abstract][Full Text] [Related]
16. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells.
Lai CF; Cheng SL
J Biol Chem; 2002 May; 277(18):15514-22. PubMed ID: 11854297
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein receptor IB signaling mediates apoptosis independently of differentiation in osteoblastic cells.
Haÿ E; Lemonnier J; Fromigué O; Guénou H; Marie PJ
J Biol Chem; 2004 Jan; 279(3):1650-8. PubMed ID: 14576167
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of BMP/Smad signaling by Tob in osteoblasts.
Yoshida Y; Tanaka S; Umemori H; Minowa O; Usui M; Ikematsu N; Hosoda E; Imamura T; Kuno J; Yamashita T; Miyazono K; Noda M; Noda T; Yamamoto T
Cell; 2000 Dec; 103(7):1085-97. PubMed ID: 11163184
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaB-independent bone morphogenetic protein/Smad signaling.
Chen S; Guttridge DC; Tang E; Shi S; Guan K; Wang CY
J Biol Chem; 2001 Oct; 276(42):39259-63. PubMed ID: 11500509
[TBL] [Abstract][Full Text] [Related]
20. The bone morphogenetic protein 2 signaling mediator Smad1 participates predominantly in osteogenic and not in chondrogenic differentiation in mesenchymal progenitors C3H10T1/2.
Ju W; Hoffmann A; Verschueren K; Tylzanowski P; Kaps C; Gross G; Huylebroeck D
J Bone Miner Res; 2000 Oct; 15(10):1889-99. PubMed ID: 11028440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
